Your browser doesn't support javascript.
loading
Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.
Rodríguez-Villodres, Ángel; Ortiz de la Rosa, José Manuel; Álvarez-Marín, Rocío; Pachón, Jerónimo; Aznar, Javier; Lepe, José Antonio; Smani, Younes.
Afiliación
  • Rodríguez-Villodres Á; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Ortiz de la Rosa JM; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Álvarez-Marín R; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Pachón J; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Aznar J; Department of Medicine, University of Seville, Seville, Spain.
  • Lepe JA; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Smani Y; Department of Microbiology, University of Seville, Seville, Spain.
Article en En | MEDLINE | ID: mdl-29061749

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperacilina / Farmacorresistencia Bacteriana Múltiple / Escherichia coli / Combinación Piperacilina y Tazobactam / Tazobactam / Antibacterianos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperacilina / Farmacorresistencia Bacteriana Múltiple / Escherichia coli / Combinación Piperacilina y Tazobactam / Tazobactam / Antibacterianos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2018 Tipo del documento: Article País de afiliación: España